Clinical Trial Update: A Study of Gimatecan (ST1481) in Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for gimatecan (ST1481) in small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• gimatecan (gimatecan)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN